And the president has pledged to give up to 60 million doses of AstraZeneca vaccine. But these doses, which are also made at the Emergent plant, are not authorized for domestic use and cannot be released in other countries until regulators consider them safe. If they are not authorized to release, Mr Biden should agree to give more than the three vaccines used here to fulfill his 80 million promise.
The president has described vaccine donations as part of a “completely new effort” to increase vaccine supply and greatly expand manufacturing capacity, mostly in the United States. To further expand the offer, Biden recently announced that it would support the waiver of intellectual property protections for coronavirus vaccines. He also assigned Mr. Zients in charge of developing a global vaccine strategy.
But activists say it is not enough to overdose and support the waiver. They argue that Biden should create the conditions for pharmaceutical companies to transfer their intellectual property to vaccine manufacturers abroad, so that other countries can establish their own vaccine manufacturing operations.
“Peter Maybarduk, director of the Public Citizens’ Access to Medicines program, on Thursday called on the administration to invest $ 25 billion in” urgent manufacturing of public vaccines in locations around the world “to make eight billion doses of vaccine using mRNA technology in one year and “share these vaccine recipes with the world.”
Asked recently if the United States was ready to do so, Andrew Slavitt, the president’s senior health adviser, dismissed the question, saying only that the United States “would play a leadership role,” but would still need “partners.” worldwide. ” ”
On Thursday, Mr. Zients said the United States has raised the Defense Production Act’s “priority rating” for three vaccine manufacturers – AstraZeneca, Novavax and Sanofi – that do not make coronavirus vaccines authorized for use in the United States. . The change means U.S. companies that supply vaccine manufacturers will be able to “make their own decisions about which orders must be fulfilled first,” Zients said.
This could free up supplies for foreign vaccine manufacturers, allowing other countries to expand their own programs.
Abdi Latif Dahir contributed the information.